Citadel Advisors’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Citadel Advisors’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-86,464	Closed	-$3.32M	–	6819
2023 Q2	$3.32M	Sell	86,464 -25,717	-23%	-$988K	﹤0.01%	2012
2023 Q1	$2.6M	Sell	112,181 -398,986	-78%	-$9.24M	﹤0.01%	2307
2022 Q4	$13.4M	Buy	511,167 +290,148	+131%	+$7.6M	﹤0.01%	1109
2022 Q3	$4.35M	Buy	221,019 +104,668	+90%	+$2.06M	﹤0.01%	1990
2022 Q2	$2.04M	Buy	116,351 +88,902	+324%	+$1.55M	﹤0.01%	2719
2022 Q1	$450K	Buy	27,449 +15,021	+121%	+$246K	﹤0.01%	4557
2021 Q4	$203K	Sell	12,428 -139,755	-92%	-$2.28M	﹤0.01%	5468
2021 Q3	$1.94M	Sell	152,183 -99,439	-40%	-$1.27M	﹤0.01%	3044
2021 Q2	$3.55M	Sell	251,622 -253,134	-50%	-$3.57M	﹤0.01%	2568
2021 Q1	$7.8M	Sell	504,756 -42	-0%	-$649	﹤0.01%	1651
2020 Q4	$8.01M	Buy	504,798 +501,844	+16,989%	+$7.96M	﹤0.01%	1411
2020 Q3	$36K	Buy	+2,954	New	+$36K	﹤0.01%	4446
2020 Q2	–	Sell	-11,631	Closed	-$159K	–	5468
2020 Q1	$159K	Buy	11,631 +343	+3%	+$4.69K	﹤0.01%	4176
2019 Q4	$67K	Buy	+11,288	New	+$67K	﹤0.01%	4350
2019 Q3	–	Sell	-12,349	Closed	-$95K	–	5268
2019 Q2	$95K	Sell	12,349 -147,443	-92%	-$1.13M	﹤0.01%	4269
2019 Q1	$3.18M	Sell	159,792 -336,353	-68%	-$6.69M	﹤0.01%	1927
2018 Q4	$6.55M	Buy	496,145 +142,289	+40%	+$1.88M	﹤0.01%	1262
2018 Q3	$13M	Buy	353,856 +35,690	+11%	+$1.31M	0.01%	960
2018 Q2	$11.1M	Buy	318,166 +285,909	+886%	+$10M	0.01%	960
2018 Q1	$1.5M	Sell	32,257 -2,656	-8%	-$124K	﹤0.01%	2143
2017 Q4	$1.31M	Buy	+34,913	New	+$1.31M	﹤0.01%	2202
2017 Q2	–	Sell	-11,784	Closed	-$633K	–	4311
2017 Q1	$633K	Buy	+11,784	New	+$633K	﹤0.01%	2438
2016 Q2	–	Sell	-12,652	Closed	-$810K	–	4040
2016 Q1	$810K	Buy	+12,652	New	+$810K	﹤0.01%	1937
2015 Q3	–	Sell	-6,541	Closed	-$992K	–	4373
2015 Q2	$992K	Buy	+6,541	New	+$992K	﹤0.01%	2145